| The impact of the COVID-19 pandemic on cardiovascular disease prevention and management CE Dale, R Takhar, R Carragher, M Katsoulis, F Torabi, S Duffield, S Kent, ... Nature Medicine, 1-7, 2023 | 93 | 2023 |
| Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland T Mueller, S Alvarez‐Madrazo, C Robertson, O Wu, M Bennie British journal of clinical pharmacology 85 (2), 422-431, 2019 | 49 | 2019 |
| Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries JJ Komen, A Pottegård, AK Mantel-Teeuwisse, T Forslund, P Hjemdahl, ... EP Europace 23 (11), 1722-1730, 2021 | 39 | 2021 |
| Time to review authorisation and funding for new cancer medicines in Europe? Inferences from the case of Olaratumab C Pontes, C Zara, J Torrent-Farnell, M Obach, C Nadal, P Vella-Bonanno, ... Applied health economics and health policy 18 (1), 5-16, 2020 | 39 | 2020 |
| Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: applying a coherent framework to drug utilisation studies T Mueller, S Alvarez‐Madrazo, C Robertson, M Bennie Pharmacoepidemiology and drug safety 26 (11), 1378-1386, 2017 | 39 | 2017 |
| The correlation between regulatory conditions and antibiotic consumption within the WHO European Region T Mueller Health Policy 120 (8), 882-889, 2016 | 39 | 2016 |
| Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study JJ Komen, A Pottegård, AK Mantel-Teeuwisse, T Forslund, P Hjemdahl, ... European Heart Journal 43 (37), 3528-3538, 2022 | 36 | 2022 |
| Initiatives and reforms across Scotland in recent years to improve prescribing; findings and global implications S MacBride-Stewart, S McTaggart, A Kurdi, J Sneddon, S McBurney, ... International Journal of Clinical and Experimental Medicine, 2021 | 24 | 2021 |
| Use of record linkage to evaluate treatment outcomes and trial eligibility in a real‐world metastatic prostate cancer population in Scotland K Baillie, T Mueller, J Pan, J Laskey, M Bennie, C Crearie, K Kavanagh, ... Pharmacoepidemiology and drug safety 29 (6), 653-663, 2020 | 20 | 2020 |
| Real‐world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population‐based study RC Rezende Macedo do Nascimento, T Mueller, B Godman, ... British journal of clinical pharmacology 86 (12), 2349-2361, 2020 | 15 | 2020 |
| Improving prescribing through big data approaches—Ten years of the Scottish Prescribing Information System M Bennie, W Malcolm, S McTaggart, T Mueller British journal of clinical pharmacology 86 (2), 250-257, 2020 | 14 | 2020 |
| An umbrella review and meta‐analysis of renin–angiotensin system drugs use and COVID‐19 outcomes A Kurdi, T Mueller, N Weir European Journal of Clinical Investigation 53 (2), e13888, 2023 | 13 | 2023 |
| Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland H Tibble, T Mueller, E Proud, E Hall, A Kurdi, C Robertson, M Bennie, ... The Lancet 401 (10371), 101-102, 2023 | 10 | 2023 |
| What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer E Dunlop, A Ferguson, T Mueller, K Baillie, J Clarke, J Laskey, A Kurdi, ... Supportive Care in Cancer 30 (4), 3141-3150, 2022 | 9 | 2022 |
| The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale descriptive analysis of trends in … CE Dale, R Takhar, R Carragher, F Torabi, M Katsoulis, S Duffield, S Kent, ... medRxiv, 2021.12. 31.21268587, 2022 | 8 | 2022 |
| Opportunities and challenges when using record linkage of routinely collected electronic health care data to evaluate outcomes of systemic anti-cancer treatment in clinical … T Mueller, J Laskey, K Baillie, J Clarke, C Crearie, K Kavanagh, J Graham, ... Health Informatics Journal 28 (1), 14604582221077055, 2022 | 6 | 2022 |
| Competencies required for general practice clinical pharmacists providing the Scottish pharmacotherapy service: a modified eDelphi study T Mueller, KE Preston, N Mcfadyen Weir, M Bennie, R Newham Health & Social Care in the Community 29 (6), e328-e337, 2021 | 6 | 2021 |
| Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis A Kurdi, N Platt, A Morrison, E Proud, K Gronkowski, T Mueller, RA Seaton, ... Expert Review of Anti-infective Therapy 21 (4), 455-475, 2023 | 5 | 2023 |
| Healthcare Costs for Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide D Rana, C Geue, K Baillie, J Pan, T Mueller, J Laskey, M Bennie, J Clarke, ... PharmacoEconomics-Open, 1-11, 2021 | 4 | 2021 |
| Implementation of pharmacist-led services in primary care: a mixed-methods exploration of pharmacists' perceptions of a national educational resource package K Preston, NM Weir, T Mueller, R Newham, M Bennie Pharmacy Practice (Granada) 19 (3), 2021 | 4 | 2021 |
